These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28596262)

  • 1. Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma.
    Tyson MD; Chang SS
    J Natl Compr Canc Netw; 2017 Jun; 15(6):835-840. PubMed ID: 28596262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
    Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
    J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
    Smaldone MC; Fung C; Uzzo RG; Haas NB
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current management of renal cell carcinoma.
    Kuusk T; Grivas N; de Bruijn R; Bex A
    Minerva Med; 2017 Aug; 108(4):357-369. PubMed ID: 28176516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.
    Patard JJ; Escudier B
    Nat Rev Clin Oncol; 2015 Mar; 12(3):131-2. PubMed ID: 25668729
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal cell carcinoma: what the surgeon and treating physician need to know.
    Chapin BF; Delacroix SE; Wood CG
    AJR Am J Roentgenol; 2011 Jun; 196(6):1255-62. PubMed ID: 21606286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.
    Speed JM; Trinh QD; Choueiri TK; Sun M
    Curr Urol Rep; 2017 Feb; 18(2):15. PubMed ID: 28213859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-Offs.
    Lobo JM; Nelson M; Nandanan N; Krupski TL
    J Urol; 2016 Jun; 195(6):1664-70. PubMed ID: 26778713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
    Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
    Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
    Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
    Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU guidelines on renal cell carcinoma: the 2010 update.
    Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
    Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
    Soares A; Monteiro FSM; Maluf FC; Bastos DA; Jardim DL; Sasse AD; Gonçalves E Silva A; Fay AP; da Rosa DAR; Wierman E; Kater F; Schutz FA; de Oliveira FNG; Morbeck IAP; Rinck JA; da Trindade KM; Maia MC; Souza VC; da Silva Neto DCV; de Almeida E Paula F; Korkes F; Carvalhal GF; Nogueira L; de Carvalho Fernandes R; Dos Reis RB; Matheus WE; Busato WFS; da Costa WH; de Cássio Zequi S
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1829-1845. PubMed ID: 32410064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
    Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
    J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Motzer RJ; Jonasch E; Agarwal N; Alva A; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Haas N; Hancock SL; Kapur P; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Nandagopal L; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Dwyer MA; Gurski LA; Motter A
    J Natl Compr Canc Netw; 2022 Jan; 20(1):71-90. PubMed ID: 34991070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
    Al-Ali BM; Ress AL; Gerger A; Pichler M
    Anticancer Res; 2012 Sep; 32(9):3727-32. PubMed ID: 22993312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
    Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
    BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma. Guidelines for diagnosis and treatment.
    Miller K
    Urol Int; 1999; 63(1):6-9. PubMed ID: 10592483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post partial nephrectomy surveillance imaging: an evidence-based approach.
    Marconi L; Gorin MA; Allaf ME
    Curr Urol Rep; 2015 Apr; 16(4):23. PubMed ID: 25749808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough?
    Patel DN; Figlin RA; Kim HL
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):907-914. PubMed ID: 27930642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
    Motzer RJ; Jonasch E; Boyle S; Carlo MI; Manley B; Agarwal N; Alva A; Beckermann K; Choueiri TK; Costello BA; Derweesh IH; Desai A; George S; Gore JL; Haas N; Hancock SL; Kyriakopoulos C; Lam ET; Lau C; Lewis B; Madoff DC; McCreery B; Michaelson MD; Mortazavi A; Nandagopal L; Pierorazio PM; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Somer B; Sosman J; Dwyer MA; Motter AD
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1160-1170. PubMed ID: 32886895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.